Version 2.73

LP262556-6Candida aurisActive


LP262556-6   Candida auris
Candida auris is a fungus that was first identified in 2009 in Japan and can cause serious infections in the blood, spinal fluid, and internal organs. This emerging fungus has spread quickly and infections have been documented all over the world. C auris is difficult to identify with the currently available phenotypic methods used by laboratories, and can be misidentified as other species of yeast. It is often resistant to multiple drugs, though resistance can differ broadly across isolates. There are currently no established breakpoints to determine susceptibility, so laboratories have relied on the breakpoints of closely related Candida species or the opinion of experts in mycology. In the United States, C auris is resistant to fluconazole in 90% of infections, to amphotericin B in 30% of infections, and to echinocandins in 5% of infections. Patients at highest risk of infection are those that have been hospitalized for a long time, those with indwelling catheters, and those who have been previously treated with antibiotic or antifungal medication. Symptoms of invasive infection include fever and chills that do not resolve after treatment with antibiotics.[https://www.cdc.gov/fungal/candida-auris/index.html] Source: Regenstrief LOINC

Basic Part Properties

Candida auris
Created On
Construct for LOINC Short Name
C auris

LOINC FHIR® API Example - CodeSystem Request Get Info


Language Variants Get Info

zh-CNChinese (China)
Synonyms: 耳道念珠菌;耳念珠菌
nl-NLDutch (Netherlands)
Candida auris
it-ITItalian (Italy)
Candida auris
es-ESSpanish (Spain)
Candia auris